Simultaneous auto-transplant and CD19 CAR T-cell 2nd line therapy followed by CD20 × CD3 bispecific antibody for refractory Burkitt lymphoma, a case report

Tools

Item Type:	Letter
Title:	Simultaneous auto-transplant and CD19 CAR T-cell 2nd line therapy followed by CD20 × CD3 bispecific antibody for refractory Burkitt lymphoma, a case report
Creators:	Stegemann, Maike ORCID: https://orcid.org/0009-0007-3961-9344, Macherndl-Spandl, Sigrid ORCID: https://orcid.org/0009-0007-1247-7948, Mairhofer, Mario ORCID: https://orcid.org/0000-0002-7218-6284, Kaltenbrunner, Sabine ORCID: https://orcid.org/0000-0002-2794-025X, Buxhofer-Ausch, Veronika ORCID: https://orcid.org/0000-0002-7369-9700, Clausen, Johannes ORCID: https://orcid.org/0000-0002-2729-9706, Petzer, Andreas ORCID: https://orcid.org/0000-0003-1595-0300 and Schmitt, Clemens A. ORCID: https://orcid.org/0000-0002-4731-2226
Source:	Leukemia & Lymphoma
ISSN:	1042-8194
Publisher:	Informa Healthcare / Taylor & Francis
Volume:	67
Number:	5
Page Range:	1147-1151
Date:	April 2026
Official Publication:	https://doi.org/10.1080/10428194.2025.2591779
PubMed:	View item in PubMed

Repository Staff Only: item control page